openPR Logo
Press release

Autoimmune Treatment Market Accelerates Amid Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - Abbott Laboratories, Amgen, Johnson & Johnson.

09-09-2025 12:09 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Autoimmune Treatment Market

Autoimmune Treatment Market

Market Overview:

The Global Autoimmune Treatment Market is predicted to reach at a Significant CAGR during the forecast period (2024-2031).

The Autoimmune Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Autoimmune Treatment market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/autoimmune-treatment-market?sz

The Autoimmune Treatment Market refers to the industry focused on developing and providing therapies that manage, suppress, or regulate abnormal immune responses causing the body to attack its own tissues. It includes biologics, immunosuppressants, monoclonal antibodies, and targeted therapies aimed at conditions like rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease, driving innovation and healthcare advancements.

Key Developments of USA and Japan:

USA:

August 29, 2025: Sanofi's Wayrilz (rilzabrutinib) was approved as the first BTK inhibitor for immune thrombocytopenia (ITP) in adults who have had an insufficient response to previous treatments.

April 29, 2025: The FDA approved Nipocalimab-aahu (Imaavy) to treat generalized myasthenia gravis (gMG).

Japan:

June 24, 2025: The Ministry of Health, Labour and Welfare (MHLW) approved Novartis Pharma K.K.'s Fabhalta (iptacopan hydrochloride hydrate) for the treatment of paroxysmal nocturnal haemoglobinuria.

August 25, 2025: MHLW approved ENHERTU (Trastuzumab Deruxtecan) for the treatment of HER2-low or HER2-ultralow metastatic breast cancer following at least one endocrine therapy.

Key Players:

Abbott Laboratories
Amgen
Johnson & Johnson
Eli Lilly & Co.
Pfizer
Roche
Astrazeneca Plc
Bristol-Myers Squibb Co.
GlaxoSmithKline Plc
Lupin Limited.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=autoimmune-treatment-market

Market Segmentation:

By Drug Class: Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other.

By Indication: Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, Other.

By Distribution Channel: Hospital Pharmacy, Pharmacy Stores, Other.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/autoimmune-treatment-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Autoimmune Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Autoimmune Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Autoimmune Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Autoimmune Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Autoimmune Treatment Market in 2025?
◆ What is the projected growth rate of the Autoimmune Treatment Market through 2033?
◆ Who are the key players in the Autoimmune Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Treatment Market Accelerates Amid Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - Abbott Laboratories, Amgen, Johnson & Johnson. here

News-ID: 4175551 • Views:

More Releases from DataM Intelligence 4Market Research

Immunology Drugs Market Poised for Breakthrough Growth Amid Rising Autoimmune and Inflammatory Disorder Cases 2025 | Top key players - Eli-Lilly, Novartis, AbbVie.
Immunology Drugs Market Poised for Breakthrough Growth Amid Rising Autoimmune an …
Market Size and Growth: The Global Immunology Drugs Market Size reached US$ 91.97 billion in 2023 and is expected to reach US$ 148.62 billion by 2031, growing at a CAGR of 6.35% during the forecast period 2024-2031. The Immunology Drugs Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
Inactivated Vaccines Market Poised for Robust Growth Amid Rising Immunization Demand 2025 | Major key players - GSK plc., Sanofi., Biological E Limited., Bharat Biotech.
Inactivated Vaccines Market Poised for Robust Growth Amid Rising Immunization De …
Market Size and Growth: The Global Inactivated Vaccines Market Size reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032. The Inactivated Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize
Circulating Tumor Cells Market Poised for Breakthrough Growth with Rising Precision Oncology Demand 2025 | Top key players - QIAGEN N.V., Bio-Techne Corporation, Biocept Inc.
Circulating Tumor Cells Market Poised for Breakthrough Growth with Rising Precis …
Market Overview: The Global Circulating Tumor Cells (CTC) Market was valued at US$ 1,095.93 Million in 2024 and is expected to reach US$ 3,406.47 Million by 2033, growing at a CAGR of 15.2% during the forecast period 2025-2033. The Circulating Tumor Cells Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
Global Basal Cell Carcinoma Treatment Market Set to Soar with Innovative Therapies by 2031 | DataM Intelligence
Global Basal Cell Carcinoma Treatment Market Set to Soar with Innovative Therapi …
Market Overview: The Global Basal Cell Carcinoma Treatment Market is expected to grow at a CAGR of 9.4% during the forecast period 2024-2031. The Basal Cell Carcinoma Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Basal Cell Carcinoma Treatment market

All 5 Releases


More Releases for Autoimmune

Autoimmune Polyglandular Syndrome Market analysis reveals CAGR of 6.20 percent t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Autoimmune Polyglandular Syndrome Type 1 Market - (By Diagnosis (Serum Autoimmune Screen, End-organ Function Tests, Blood Tests, Others), Age of Onset (Childhood, Adult, Adolescent), Treatment (Medication, Hormone Replacement Therapy, Others), Dosage Form (Tablet, Capsule, Others), Route of Administration (Oral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)),
Reshaping Autoimmune Therapy Landscape: Protheragen Announces Small Molecule Dru …
Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune diseases. New York, USA - Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune conditions. From target identification to preclinical studies, Protheragen leverages its expertise in small molecule drug design and development to offer tailored services that provide biotech and pharmaceutical companies
Autoimmune Disease Diagnosis Market - Strength in Knowledge, Defying Autoimmune …
Newark, New Castle, USA: The "Autoimmune Disease Diagnosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Autoimmune Disease Diagnosis Market: https://www.growthplusreports.com/report/autoimmune-disease-diagnosis-market/7616 This latest report researches the industry structure,
Autoimmune Drugs Market: Understanding How They Work and Their Importance in Tre …
Allied Market Research recently said Autoimmune diseases are a group of disorders in which the body's immune system attacks its own healthy tissues, mistaking them for foreign invaders. These diseases can affect any part of the body, including the joints, skin, and organs. They can be debilitating, chronic, and sometimes life-threatening. Autoimmune drugs are medications that help to suppress or modulate the immune system's response to prevent it from attacking
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html To reduce effects of such hindrances, the new entrants are
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics include